Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) EBITDA (2009 - 2026)

Updated

Immucell (ICCC) recorded EBITDA of $1.42 million in Q3 2026, up 86.1% from $763,096 a year earlier but down 41.0% from the prior quarter.

Analysis

Immucell (ICCC) EBITDA (2009 - 2026) Analysis & Trends

On a TTM basis, Immucell's EBITDA came in at $6.99 million as of Sep 30, 2026, up 35.3% year-over-year; for FY2025, it was $4.51 million, up 291.4% from FY2024.

  • Annual EBITDA has a five-year compound annual growth rate of 32.9% (FY2020 to FY2025).
  • Across earlier years, EBITDA came in at $1.15 million in FY2024, -$2.97 million in FY2023, $223,060 in FY2022 (-91.9%) and $2.75 million in FY2021 (+152.9%).
  • Quarterly EBITDA has ranged from -$1.59 million in Q1 2023 to $2.5 million in Q1 2026 over the past five years.
  • On a year-over-year basis, EBITDA has increased for three consecutive quarters, with growth averaging 159.9% over the last seven quarters.
  • Peak year-over-year performance for EBITDA in the last five years was growth of 502.7% in Q3 2025, against a decline of 97.8% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.41 million (Q2 2026), $2.5 million (Q1 2026) and $659,449 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 8.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 8.16 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 5.99 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.20 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 7.05 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.42 Mn
Jun 30, 2026 2.41 Mn
Mar 31, 2026 2.50 Mn
Dec 31, 2025 659,449.00
Sep 30, 2025 763,096.00
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.82 Mn
Dec 31, 2024 1.32 Mn
Sep 30, 2024 126,614.00
Jun 30, 2024 -689,260.00
Mar 31, 2024 392,471.00
Dec 31, 2023 699,849.00
Sep 30, 2023 -461,485.00
Jun 30, 2023 -611,086.00
Mar 31, 2023 -1.59 Mn
Dec 31, 2022 -1.02 Mn
Sep 30, 2022 24,145.00
Jun 30, 2022 18,983.00
Mar 31, 2022 1.20 Mn
Dec 31, 2021 753,349.00
API Access

Immucell EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ICCC&period=max&api_key=YOUR_API_KEY